Cansino Biologics Inc logo

6185 - Cansino Biologics Inc Share Price

HK$222.8 4.0  1.8%

Last Trade - 7:15am

Sector
Healthcare
Size
Large Cap
Market Cap £5.04bn
Enterprise Value £4.97bn
Revenue £n/a
Position in Universe 255th / 5946
Bullish
Bearish
Unlock 6185 Revenue
Momentum
Relative Strength (%)
1m +18.5%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -23.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 1.13 0.000 297 2,417
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2019, Cansino Biologics Inc revenues decreased from RMB1.1M to RMB0K. Net loss increased 13% to RMB156.8M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Employee benefits expenses increase of 45% to RMB87.5M (expense), Other Trading Income, Net decrease of 73% to RMB3.4M (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for 6185
Graphical History

Revenue

6185 Revenue Unlock 6185 Revenue

Net Income

6185 Net Income Unlock 6185 Revenue

Normalised EPS

6185 Normalised EPS Unlock 6185 Revenue

PE Ratio Range

6185 PE Ratio Range Unlock 6185 Revenue

Dividend Yield Range

6185 Dividend Yield Range Unlock 6185 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
6185 EPS Forecasts Unlock 6185 Revenue
Profile Summary

CANSINO BIOLOGICS INC., formerly Tianjin CanSino Biotechnology Inc., is a China-based company principally engaged in the research and development, manufacture and commercialization of vaccine products for human use. The Company’s core products consist of two vaccine candidates, namely MCV4 candidate and MCV2 candidate. The Company mainly operates its business in the domestic market.

Directors
Last Annual December 31st, 2019
Last Interim December 31st, 2019
Incorporated January 13, 2009
Public Since March 28, 2019
No. of Shareholders: n/a
No. of Employees: 429
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Stock Exchange of Hong Kong Limited
Shares in Issue 222,649,899
Free Float (0.0%)
Eligible for
ISAs
SIPPs
6185 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 6185
Upcoming Events for 6185
Frequently Asked Questions for Cansino Biologics Inc
What is the Cansino Biologics Inc share price?

As of 7:15am, shares in Cansino Biologics Inc are trading at HK$222.8, giving the company a market capitalisation of £5.04bn. This share price information is delayed by 15 minutes.

How has the Cansino Biologics Inc share price performed this year?

Shares in Cansino Biologics Inc are currently trading at HK$222.8 and the price has moved by 0.485k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cansino Biologics Inc price has moved by 0.530k% over the past year.

What are the analyst and broker recommendations for Cansino Biologics Inc?

Of the analysts with advisory recommendations for Cansino Biologics Inc, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Cansino Biologics Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Cansino Biologics Inc next release its financial results?

Cansino Biologics Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the Cansino Biologics Inc dividend yield?

Cansino Biologics Inc does not currently pay a dividend.

Does Cansino Biologics Inc pay a dividend?

Cansino Biologics Inc does not currently pay a dividend.

When does Cansino Biologics Inc next pay dividends?

Cansino Biologics Inc does not currently pay a dividend.

How do I buy Cansino Biologics Inc shares?

To buy shares in Cansino Biologics Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Cansino Biologics Inc?

Shares in Cansino Biologics Inc are currently trading at HK$222.8, giving the company a market capitalisation of £5.04bn.

Where are Cansino Biologics Inc shares listed? Where are Cansino Biologics Inc shares listed?

Here are the trading details for Cansino Biologics Inc:

Country of listing: Hong Kong
Exchange: HKG
Ticker Symbol: 6185
What kind of share is Cansino Biologics Inc?

Based on an overall assessment of its quality, value and momentum, Cansino Biologics Inc is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Cansino Biologics Inc share price forecast 2020?

Shares in Cansino Biologics Inc are currently priced at HK$222.8. At that level they are trading at 46.78% premium to the analyst consensus target price of 0.00.

Analysts covering Cansino Biologics Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.4394180998 for the next financial year.

How can I tell whether the Cansino Biologics Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cansino Biologics Inc. Over the past six months, the relative strength of its shares against the market has been 0.325k%. At the current price of HK$222.8, shares in Cansino Biologics Inc are trading at 0.128k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Cansino Biologics Inc PE Ratio?

We were not able to find PE ratio data for Cansino Biologics Inc.

Who are the key directors of Cansino Biologics Inc?

Cansino Biologics Inc's management team is headed by:

Xuefeng Yu - CHM
Huihua Mao - SVP
Dongxu Qiu - SVP
Shou Bai Chao - COO
Zhu Tao - CSO
Qiang Xu - NED
Liang Lin - NED
Wing-Yu Leung - NED
Jing Wang - VFN
Jin Cui - SEC
Ming King Chiu - SEC
Shuifa Gui - NID
Jianzhong Liu - NID
Who are the major shareholders of Cansino Biologics Inc?

Here are the top five shareholders of Cansino Biologics Inc based on the size of their shareholding:

Lilly Asia Ventures Venture Capital
Percentage owned: 15.52% (20.6m shares)
Capital Research Global Investors Investment Advisor
Percentage owned: 13.01% (17.3m shares)
Qiming Venture Partners Venture Capital
Percentage owned: 9.83% (13.0m shares)
Mao (Huihua) Individual Investor
Percentage owned: 8.99% (11.9m shares)
Yu (Xuefeng) Individual Investor
Percentage owned: 8.74% (11.6m shares)
Similar to 6185
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.